{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:23:36Z","timestamp":1790619816538,"version":"4.1.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Global Epidemiology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.gloepi.2024.100158","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T21:54:27Z","timestamp":1723154067000},"page":"100158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Incidence and prevalence of autoimmune diseases in China: A systematic review and meta-analysis of epidemiological studies"],"prefix":"10.1016","volume":"8","author":[{"given":"Olaa","family":"Mohamed-Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianhan","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiana","family":"Kartsonaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Bragg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.gloepi.2024.100158_bb0005","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/joim.12395","article-title":"Human autoimmune diseases: a comprehensive update","volume":"278","author":"Wang","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/j.gloepi.2024.100158_bb0010","article-title":"The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention","volume":"80","author":"Miller","year":"2022","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"10.1016\/j.gloepi.2024.100158_bb0015","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1586\/14737167.2015.1065733","article-title":"The indirect costs of systemic autoimmune diseases, systemic lupus erythematosus, systemic sclerosis and sarcoidosis: a summary of 2012 real-life data from the Social Insurance Institution in Poland","volume":"15","author":"Kawalec","year":"2015","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"10354","key":"10.1016\/j.gloepi.2024.100158_bb0020","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(22)01349-6","article-title":"Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK","volume":"400","author":"Conrad","year":"2022","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.gloepi.2024.100158_bb0025","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","article-title":"The global burden of IBD: from 2015 to 2025","volume":"12","author":"Kaplan","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.gloepi.2024.100158_bb0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/clin.1997.4412","article-title":"Epidemiology and estimated population burden of selected autoimmune diseases in the United States","volume":"84","author":"Jacobson","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"issue":"1","key":"10.1016\/j.gloepi.2024.100158_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2007.05.002","article-title":"Epidemiology of autoimmune diseases in Denmark","volume":"29","author":"Eaton","year":"2007","journal-title":"J Autoimmun"},{"issue":"3\u20134","key":"10.1016\/j.gloepi.2024.100158_bb0040","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jaut.2009.09.008","article-title":"Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases","volume":"33","author":"Cooper","year":"2009","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.gloepi.2024.100158_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102423","article-title":"Comparative United States autoimmune disease rates for 2010-2016 by sex, geographic region, and race","volume":"19","author":"Roberts","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.gloepi.2024.100158_bb0050","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s12916-022-02544-5","article-title":"Early onset of immune-mediated diseases in minority ethnic groups in the UK","volume":"20","author":"Sharma-Oates","year":"2022","journal-title":"BMC Med"},{"issue":"9","key":"10.1016\/j.gloepi.2024.100158_bb0055","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41584-021-00668-1","article-title":"Global epidemiology of systemic lupus erythematosus","volume":"17","author":"Barber","year":"2021","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"10.1016\/j.gloepi.2024.100158_bb0060","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S2468-1253(16)30077-2","article-title":"Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China","volume":"1","author":"Kaplan","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.gloepi.2024.100158_bb0065","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.healthpol.2003.07.005","article-title":"Changing health in China: re-evaluating the epidemiological transition model","volume":"67","author":"Cook","year":"2004","journal-title":"Health Policy"},{"key":"10.1016\/j.gloepi.2024.100158_bb0070","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3389\/fmed.2018.00183","article-title":"A systematic review of epidemiology and risk factors associated with Chinese inflammatory bowel disease","volume":"5","author":"Cui","year":"2018","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"10.1016\/j.gloepi.2024.100158_bb0075","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1751-2980.2010.00431.x","article-title":"Prevalence and incidence rates of Crohn\u2019s disease in mainland China: a meta-analysis of 55 years of research","volume":"11","author":"Zheng","year":"2010","journal-title":"J Dig Dis"},{"issue":"1","key":"10.1016\/j.gloepi.2024.100158_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst Rev"},{"issue":"15","key":"10.1016\/j.gloepi.2024.100158_bb0085","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.gloepi.2024.100158_bb0090","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","article-title":"Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data","volume":"13","author":"Munn","year":"2015","journal-title":"Int J Evid Based Healthc"},{"issue":"4","key":"10.1016\/j.gloepi.2024.100158_bb0095","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.gloepi.2024.100158_bb0100","series-title":"ckbplotr: Create CKB plots","author":"Wright","year":"2022"},{"key":"10.1016\/j.gloepi.2024.100158_bb0105","series-title":"ggplot2: Elegant graphics for data analysis","author":"Wickham","year":"2016"},{"key":"10.1016\/j.gloepi.2024.100158_bb0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2288-14-25","article-title":"The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method","volume":"14","author":"IntHout","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.gloepi.2024.100158_bb0115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12874-015-0091-1","article-title":"Hartung-Knapp-Sidik-Jonkman approach and its modification for random-effects meta-analysis with few studies","volume":"15","author":"R\u00f6ver","year":"2015","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"10.1016\/j.gloepi.2024.100158_bb0120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","article-title":"Assessing heterogeneity in meta-analysis: Q statistic or I2 index?","volume":"11","author":"Huedo-Medina","year":"2006","journal-title":"Psychol Methods"},{"issue":"8","key":"10.1016\/j.gloepi.2024.100158_bb0125","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jclinepi.2014.03.003","article-title":"In meta-analyses of proportion studies, funnel plots were found to be an inaccurate method of assessing publication bias","volume":"67","author":"Hunter","year":"2014","journal-title":"J Clin Epidemiol"},{"issue":"13","key":"10.1016\/j.gloepi.2024.100158_bb0155","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1097\/01.MIB.0000435436.99612.27","article-title":"Increasing incidence and lifetime risk of inflammatory bowel disease in Taiwan: a nationwide study in a low-endemic area 1998-2010","volume":"19","author":"Chuang","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"10.1016\/j.gloepi.2024.100158_bb0160","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1097\/MIB.0000000000000846","article-title":"Epidemiology of inflammatory bowel disease from 1981 to 2014: results from a territory-wide population-based registry in Hong Kong","volume":"22","author":"Ng","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.gloepi.2024.100158_bb0300","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41395-018-0233-2","article-title":"Population density and risk of inflammatory bowel disease: a prospective population-based study in 13 countries or regions in Asia-Pacific","volume":"114","author":"Ng","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.gloepi.2024.100158_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101296","article-title":"The incidence of inflammatory bowel disease in northern China: a prospective population-based study","volume":"9","author":"Yang","year":"2014","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.gloepi.2024.100158_bb0325","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/jgh.12164","article-title":"Incidence and clinical characteristics of inflammatory bowel disease in a developed region of Guangdong Province, China: a prospective population-based study","volume":"28","author":"Zeng","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.gloepi.2024.100158_bb0330","first-page":"1839","article-title":"First prospective, population-based inflammatory bowel disease incidence study in mainland of China: the emergence of \u201cwestern\u201d disease","volume":"19","author":"Zhao","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gloepi.2024.100158_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanwpc.2020.100010","article-title":"Incidence of multiple sclerosis in China: a nationwide hospital-based study","volume":"1","author":"Tian","year":"2020","journal-title":"Lancet Regional Health-Western Pacific"},{"issue":"3","key":"10.1016\/j.gloepi.2024.100158_bb0135","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000229779","article-title":"Population-based epidemiological study of neurological diseases in Taiwan: I. Creutzfeldt-Jakob disease and multiple sclerosis","volume":"33","author":"Lai","year":"2009","journal-title":"Neuroepidemiology"},{"issue":"1","key":"10.1016\/j.gloepi.2024.100158_bb0140","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1038\/s41598-021-86347-3","article-title":"Epidemiology, treatment patterns and healthcare utilizations in multiple sclerosis in Taiwan","volume":"11","author":"Hsu","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.gloepi.2024.100158_bb0145","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00296-012-2411-7","article-title":"Rheumatoid arthritis prevalence, incidence, and mortality rates: a nationwide population study in Taiwan","volume":"33","author":"Kuo","year":"2013","journal-title":"Rheumatol Int"},{"issue":"26","key":"10.1016\/j.gloepi.2024.100158_bb0150","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1056\/NEJMoa054022","article-title":"Effect of iodine intake on thyroid diseases in China","volume":"354","author":"Teng","year":"2006","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.gloepi.2024.100158_bb0165","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/01.MIB.0000201098.26450.ae","article-title":"Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, Central China","volume":"12","author":"Jiang","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gloepi.2024.100158_bb0320","article-title":"Trend and geographic variation in incidence and prevalence of inflammatory bowel disease in regions across China: a Nationwide employee study between 2013 and 2016","volume":"9","author":"Yang","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"82","key":"10.1016\/j.gloepi.2024.100158_bb0430","first-page":"467","article-title":"Patterns of traditional Chinese medicine use in patients with inflammatory bowel disease: a population study in Taiwan","volume":"55","author":"Chen","year":"2008","journal-title":"Hepato-Gastroenterology"},{"issue":"5","key":"10.1016\/j.gloepi.2024.100158_bb0310","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1111\/ene.14764","article-title":"Urban prevalence of multiple sclerosis in China: a population-based study in six provinces","volume":"28","author":"Xu","year":"2021","journal-title":"Eur J Neurol"},{"issue":"8","key":"10.1016\/j.gloepi.2024.100158_bb0350","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1177\/13524585211061341","article-title":"Epidemiological investigation of multiple sclerosis and related medical utilisation in Taiwan","volume":"28","author":"Liao","year":"2022","journal-title":"Mult Scler"},{"issue":"18","key":"10.1016\/j.gloepi.2024.100158_bb0435","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1212\/01.wnl.0000260695.72980.b7","article-title":"A population-based survey of multiple sclerosis in Shanghai, China","volume":"68","author":"Cheng","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.gloepi.2024.100158_bb0445","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jns.2007.11.006","article-title":"The clinical course of multiple sclerosis patients in Hong Kong","volume":"268","author":"Lau","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.gloepi.2024.100158_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104151","article-title":"Prevalence of multiple sclerosis in Guangzhou, China: a population-based case-finding prospective study","volume":"68","author":"Liu","year":"2022","journal-title":"Mult Scler Relat Disord"},{"issue":"10","key":"10.1016\/j.gloepi.2024.100158_bb0455","first-page":"500","article-title":"Multiple sclerosis in Taiwan","volume":"67","author":"Tsai","year":"2004","journal-title":"J Chin Med Assoc JCMA"},{"issue":"9214933","key":"10.1016\/j.gloepi.2024.100158_bb0375","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.jfma.2019.06.016","article-title":"Trends in prevalence and incidence of diabetes mellitus from 2005 to 2014 in Taiwan","volume":"118","author":"Sheen","year":"2019","journal-title":"J Formosan Med Assoc"},{"issue":"2","key":"10.1016\/j.gloepi.2024.100158_bb0170","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/acr.21820","article-title":"Prevalence and incidence in patients with autoimmune rheumatic diseases: a nationwide population-based study in Taiwan","volume":"65","author":"Yu","year":"2013","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.gloepi.2024.100158_bb0395","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1038\/s41598-021-84957-5","article-title":"The prevalence and incidence of systemic lupus erythematosus in Taiwan: a nationwide population-based study","volume":"11","author":"Leong","year":"2021","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.gloepi.2024.100158_bb0415","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1007\/s00296-012-2643-6","article-title":"Burden of systemic lupus erythematosus in Taiwan: a population-based survey","volume":"33","author":"Yeh","year":"2013","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1016\/j.gloepi.2024.100158_bb0465","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/rheumatology\/ker370","article-title":"Epidemiology of eight common rheumatic diseases in China: a large-scale cross-sectional survey in Beijing","volume":"51","author":"Li","year":"2012","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.gloepi.2024.100158_bb0470","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1191\/0961203303lu451xx","article-title":"Lupus in Hong Kong Chinese","volume":"12","author":"Mok","year":"2003","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.gloepi.2024.100158_bb0475","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00296-013-2902-1","article-title":"Prevalence of systemic lupus erythematosus and risk factors in rural areas of Anhui Province","volume":"34","author":"Zou","year":"2014","journal-title":"Rheumatol Int"},{"issue":"6","key":"10.1016\/j.gloepi.2024.100158_bb0175","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3111\/13696998.2011.611201","article-title":"The impact of rheumatoid arthritis on the burden of disease in urban China","volume":"14","author":"Langley","year":"2011","journal-title":"J Med Econ"},{"issue":"10","key":"10.1016\/j.gloepi.2024.100158_bb0480","first-page":"2245","article-title":"Prevalence of rheumatic symptoms, rheumatoid arthritis, ankylosing spondylitis, and gout in Shanghai, China: a COPCORD study","volume":"30","author":"Dai","year":"2003","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.gloepi.2024.100158_bb0485","first-page":"1136","article-title":"Study on the prevalence of arthritis and relevant factors in Shanghai","volume":"24","author":"Shi","year":"2003","journal-title":"Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi"},{"issue":"41","key":"10.1016\/j.gloepi.2024.100158_bb0490","first-page":"3309","article-title":"Epidemiology of rheumatoid arthritis in middle-aged and elderly population in Luohe City, Henan Province","volume":"93","author":"Sun","year":"2013","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"3","key":"10.1016\/j.gloepi.2024.100158_bb0495","first-page":"193","article-title":"10-year epidemiological study on rheumatic diseases in Shantou area","volume":"36","author":"Zeng","year":"1997","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"11","key":"10.1016\/j.gloepi.2024.100158_bb0500","first-page":"1127","article-title":"Study on the prevalence rate of rheumatoid arthritis in Zhuang nationality population from Nanning, Guangxi","volume":"28","author":"Zeng","year":"2007","journal-title":"Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi"},{"issue":"9","key":"10.1016\/j.gloepi.2024.100158_bb0505","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138492","article-title":"Changes in the prevalence of rheumatic diseases in Shantou, China, in the past three decades: a COPCORD study","volume":"10","author":"Zeng","year":"2015","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.gloepi.2024.100158_bb0510","first-page":"79","article-title":"Rheumatic diseases in China","volume":"34","author":"Zhang","year":"1995","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.gloepi.2024.100158_bb0180","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jtemb.2016.04.003","article-title":"Incidence of thyroid diseases in Zhejiang Province, China, after 15 years of salt iodization","volume":"36","author":"Gu","year":"2016","journal-title":"J Trace Elem Med Biol"},{"issue":"8","key":"10.1016\/j.gloepi.2024.100158_bb0185","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1017\/S0007114520001786","article-title":"Autoimmune thyroid diseases after 25 years of universal salt iodisation: an epidemiological study of Chinese adults in areas with different water iodine levels","volume":"124","author":"Wan","year":"2020","journal-title":"Br J Nutr"},{"issue":"1","key":"10.1016\/j.gloepi.2024.100158_bb0515","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3901\/JME.2008.01.031","article-title":"A large scale epidemiological survey of Graves\u2019 disease in Daqing area","volume":"113","author":"Li","year":"2000","journal-title":"Chin Med J (Engl)"},{"issue":"8","key":"10.1016\/j.gloepi.2024.100158_bb0520","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1089\/thy.2015.0613","article-title":"Iodine status and prevalence of thyroid disorders after introduction of mandatory universal salt iodization for 16 years in China: a cross-sectional study in 10 cities","volume":"26","author":"Shan","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.gloepi.2024.100158_bb0525","article-title":"Hyperthyroidism prevalence in China after universal salt iodization","volume":"12","author":"Wang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"10.1016\/j.gloepi.2024.100158_bb0530","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1210\/jc.2015-2222","article-title":"Low population selenium status is associated with increased prevalence of thyroid disease","volume":"100","author":"Wu","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"10114","key":"10.1016\/j.gloepi.2024.100158_bb0190","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gloepi.2024.100158_bb0195","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gloepi.2024.100158_bb0200","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2377-13-128","article-title":"Incidence and prevalence of multiple sclerosis in Europe: a systematic review","volume":"13","author":"Kingwell","year":"2013","journal-title":"BMC Neurol"},{"issue":"3","key":"10.1016\/j.gloepi.2024.100158_bb0250","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000342779","article-title":"Incidence and prevalence of multiple sclerosis in the Americas: a systematic review","volume":"40","author":"Evans","year":"2013","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.gloepi.2024.100158_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103119","article-title":"Multiple sclerosis epidemiology in Asia and Oceania; a systematic review and meta-analysis","volume":"54","author":"Forouhari","year":"2021","journal-title":"Mult Scler Relat Disord"},{"issue":"8","key":"10.1016\/j.gloepi.2024.100158_bb0210","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/j.1440-1746.2012.07150.x","article-title":"Inflammatory bowel disease in Asia: a systematic review","volume":"27","author":"Prideaux","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.gloepi.2024.100158_bb0215","doi-asserted-by":"crossref","first-page":"98","DOI":"10.34172\/hpp.2020.18","article-title":"Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis","volume":"10","author":"Mobasseri","year":"2020","journal-title":"Health Promot Perspect"},{"issue":"5","key":"10.1016\/j.gloepi.2024.100158_bb0260","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3899\/jrheum.200367","article-title":"The prevalence of rheumatoid arthritis: a systematic review of population-based studies","volume":"48","author":"Almutairi","year":"2021","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.gloepi.2024.100158_bb0265","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.semarthrit.2006.08.006","article-title":"Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review","volume":"36","author":"Alamanos","year":"2006","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.gloepi.2024.100158_bb0220","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrendo.2018.18","article-title":"Global epidemiology of hyperthyroidism and hypothyroidism","volume":"14","author":"Taylor","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.gloepi.2024.100158_bb0270","doi-asserted-by":"crossref","first-page":"1020709","DOI":"10.3389\/fpubh.2022.1020709","article-title":"Global prevalence and epidemiological trends of Hashimoto\u2019s thyroiditis in adults: a systematic review and meta-analysis","volume":"10","author":"Hu","year":"2022","journal-title":"Front Public Health"},{"issue":"2","key":"10.1016\/j.gloepi.2024.100158_bb0225","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1530\/eje.1.02210","article-title":"The Danish investigation on iodine intake and thyroid disease, DanThyr: status and perspectives","volume":"155","author":"Laurberg","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.gloepi.2024.100158_bb0230","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s12026-021-09192-6","article-title":"Iodoprophylaxis and thyroid autoimmunity: an update","volume":"69","author":"Teti","year":"2021","journal-title":"Immunol Res"},{"issue":"5","key":"10.1016\/j.gloepi.2024.100158_bb0235","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3325\/cmj.2011.52.615","article-title":"Ten-year follow-up of thyroid epidemiology in Slovenia after increase in salt iodization","volume":"52","author":"Zaletel","year":"2011","journal-title":"Croat Med J"},{"issue":"2","key":"10.1016\/j.gloepi.2024.100158_bb0240","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12020-012-9703-2","article-title":"The incidence and prevalence of thyroid autoimmunity","volume":"42","author":"McLeod","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.gloepi.2024.100158_bb0245","author":"World Bank"}],"container-title":["Global Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590113324000245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590113324000245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T03:30:56Z","timestamp":1734060656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590113324000245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":82,"alternative-id":["S2590113324000245"],"URL":"https:\/\/doi.org\/10.1016\/j.gloepi.2024.100158","relation":{},"ISSN":["2590-1133"],"issn-type":[{"value":"2590-1133","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and prevalence of autoimmune diseases in China: A systematic review and meta-analysis of epidemiological studies","name":"articletitle","label":"Article Title"},{"value":"Global Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gloepi.2024.100158","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100158"}}